Vanguard Global Advisers
GH icon

Vanguard Global Advisers’s Guardant Health GH Stock Holding History

Vanguard Global Advisers’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.59M Sell
57,268
-794
-1% -$86.4K ﹤0.01% 658
2026
Q1 		$5.36M Buy
+58,062
New +$5.83M ﹤0.01% 747

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Global Advisers's GH Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Guardant Health (GH) stake by 1.4% in Q2 2026, selling an estimated $86.4K and leaving 57,268 shares worth $8.59M. The position accounts for ﹤0.01% of the portfolio, ranked #658.

Vanguard Global Advisers first reported a position in GH in Q1 2026 and has held it in 2 quarters since. 585 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Vanguard Global Advisers held 57,268 shares of Guardant Health worth $8.59M as of Q2 2026.
  • Vanguard Global Advisers sold 794 Guardant Health shares in Q2 2026, an estimated $86.4K.
  • Guardant Health made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #658 holding.
  • Vanguard Global Advisers first reported a position in Guardant Health in Q1 2026 and has held it in 2 quarters since.
  • 585 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.